Insider · CIK 0001380466
Ronald E Osman
Files at INTI (Inhibitor Therapeutics, Inc.). First filing -, latest -.
Ronald E Osman files SEC Form 4 as director and 10% owner at INTI (Inhibitor Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Ronald E Osman has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 1, 2025 | INTI Inhibitor Therapeutics, Inc. | AGrant or award Common Stockindirect: See Footnotes | +50,000 | $0.00 | $0 | 23,554,985 | Apr 7, 2025 |
Questions about Ronald E Osman
Answered from the filings on this page, as of the latest one.
Is Ronald E Osman buying or selling?
Ronald E Osman has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Ronald E Osman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Ronald E Osman has 0.
Where does Ronald E Osman file Form 4?
Ronald E Osman has filed Form 4 at INTI (Inhibitor Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.